EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Patient With Advanced Aggressive B2 Thymoma Achieved Positive Outcomes Post CAP‐Endostar Combination Therapy

Min Zhang, Jingjing Zhang iD, Kelei Zhao, Xiaohan Yuan, Jinghang Zhang, Yanting Liu, Ping Lu

The Clinical Respiratory Journal · 2025

DOI: 10.1111/crj.70081 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The Clinical Respiratory Journal, 2025. Verfasst von Min Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The First Affiliated Hospital of Xinxiang Medical University, Weihui, China. Hauptthemen laut MEDLINE: Thymoma, Thymus Neoplasms. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Henan Provincial Department of Education, Henan Provincial Department of Science and Technology, Xinxiang Medical College.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This case report features a patient with an invasive thymoma. The patient presented with an anterior mediastinal mass that invaded the left brachiocephalic trunk vein, resulting in the formation of a carcinoma thrombus in the right atrium, superior vena cava, left brachiocephalic trunk vein, and left internal jugular vein (Masaoka stage IV). No indication for surgery was assessed by surgical consultation. After six cycles of chemotherapy and chest radiotherapy, the tumor size decreased from 72.43 to 24 mm, showing a significant improvement in patient efficacy. After a follow‐up of 50 months, the patient remained well, without local recurrence or distal metastasis, and maintained a partial response (PR).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThymomaThymus NeoplasmsHumansCombined Modality TherapyNeoplasm InvasivenessNeoplasm StagingTomography, X-Ray ComputedTreatment OutcomeRecombinant ProteinsEndostatins

Stichwörter der Autor:innen

Endostar (recombinant human endostatin injection)radiation therapythymic tumors

Substanzen

endostar proteinRecombinant ProteinsEndostatins

Autor:innen und Institutionen

  • Department of Oncology, The First Affiliated Hospital of Xinxiang Medical University, Weihui, China.
  • Department of Pathology, The First Affiliated Hospital of Xinxiang Medical University, Weihui, China.

ORCID-Profile: Jingjing Zhang

Förderung

  • Henan Provincial Department of Education
  • Henan Provincial Department of Science and Technology
  • Xinxiang Medical College
  • Education Department of Henan Province
  • Science and Technology Department of Henan Province

Zitieren

APA

Zhang, M., Zhang, J., Zhao, K., Yuan, X., Zhang, J., Liu, Y., & Lu, P. (2025). Patient With Advanced Aggressive B2 Thymoma Achieved Positive Outcomes Post CAP‐Endostar Combination Therapy. The Clinical Respiratory Journal. https://doi.org/10.1111/crj.70081

Vancouver

Zhang M, Zhang J, Zhao K, Yuan X, Zhang J, Liu Y, et al. Patient With Advanced Aggressive B2 Thymoma Achieved Positive Outcomes Post CAP‐Endostar Combination Therapy. The Clinical Respiratory Journal. 2025. doi:10.1111/crj.70081

BibTeX
@article{Zhang2025,
  author = {Zhang, Min and Zhang, Jingjing and Zhao, Kelei and Yuan, Xiaohan and Zhang, Jinghang and Liu, Yanting and Lu, Ping},
  title = {Patient With Advanced Aggressive B2 Thymoma Achieved Positive Outcomes Post CAP‐Endostar Combination Therapy},
  journal = {The Clinical Respiratory Journal},
  year = {2025},
  doi = {10.1111/crj.70081}
}
Kostenlos starten →